Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. To compare patient and transfusion...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 2007-11, Vol.176 (9), p.886-891 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 891 |
---|---|
container_issue | 9 |
container_start_page | 886 |
container_title | American journal of respiratory and critical care medicine |
container_volume | 176 |
creator | Gajic, Ognjen Rana, Rimki Winters, Jeffrey L Yilmaz, Murat Mendez, Jose L Rickman, Otis B O'Byrne, Megan M Evenson, Laura K Malinchoc, Michael DeGoey, Steven R Afessa, Bekele Hubmayr, Rolf D Moore, S. Breanndan |
description | Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies.
To compare patient and transfusion risk factors between patients who do and do not develop ALI.
In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis.
Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI.
Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI. |
doi_str_mv | 10.1164/rccm.200702-271OC |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2048675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68414645</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-75652930b973f80c8221761e063b49ea9db1223e729be1e1630815f3763b0a073</originalsourceid><addsrcrecordid>eNpdkd2L1DAUxYso7of-Ab5I8EHYh665aZsPH4SlqDsw7Aqu4FtIM7czGdJ2NmlX5r83dYbV9SmB-zuHe-7JsjdALwF4-SFY210ySgVlORNwWz_LTqEqqrxUgj5PfyqKvCzVz5PsLMYtpcAk0JfZCQjOuAJ6mjV3wfSxnaIb-jygNyOuyJWdRiTLqV-TRb-dwp64nowbJHVwo7PG-z1ZeP-RfAtD3KEd3QOSG4yztjYR83roxzB48n2cVvtX2YvW-Iivj-959uPL57v6Ol_efl3UV8vcMsnGXFS8YqqgjRJFK6mVjKU1ASkvmlKhUasGGCtQMNUgIPCCSqjaQqQ5NSnpefbp4Lubmg5XFtMOxutdcJ0Jez0Yp59OerfR6-FBM1pKLqpk8P5oEIb7KcXRnYsWvTc9DlPUXJZQ8nIG3_0Hbocp9CmcBqUqRSsJCYIDZNORYsD2cROgeq5Pz_XpQ336T31J8_bfCH8Vx74ScHEANm69-eUC6tilOhIO2mxnw4RqpaXkxW8eVqUm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199590581</pqid></control><display><type>article</type><title>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Gajic, Ognjen ; Rana, Rimki ; Winters, Jeffrey L ; Yilmaz, Murat ; Mendez, Jose L ; Rickman, Otis B ; O'Byrne, Megan M ; Evenson, Laura K ; Malinchoc, Michael ; DeGoey, Steven R ; Afessa, Bekele ; Hubmayr, Rolf D ; Moore, S. Breanndan</creator><creatorcontrib>Gajic, Ognjen ; Rana, Rimki ; Winters, Jeffrey L ; Yilmaz, Murat ; Mendez, Jose L ; Rickman, Otis B ; O'Byrne, Megan M ; Evenson, Laura K ; Malinchoc, Michael ; DeGoey, Steven R ; Afessa, Bekele ; Hubmayr, Rolf D ; Moore, S. Breanndan</creatorcontrib><description>Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies.
To compare patient and transfusion risk factors between patients who do and do not develop ALI.
In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis.
Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI.
Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200702-271OC</identifier><identifier>PMID: 17626910</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>Aged ; Alcohol ; Antibodies ; B. Critical Care ; Blood & organ donations ; Blood products ; Blood Transfusion - methods ; Case-Control Studies ; Cohort analysis ; Cohort Studies ; Critical Care ; Female ; Granulocytes ; Humans ; Incidence ; Leukocytes ; Male ; Middle Aged ; Mortality ; Patients ; Plasma ; Respiratory Distress Syndrome - epidemiology ; Respiratory Distress Syndrome - therapy ; Risk Factors ; Sepsis ; Time Factors ; Transfusion Reaction ; Treatment Outcome</subject><ispartof>American journal of respiratory and critical care medicine, 2007-11, Vol.176 (9), p.886-891</ispartof><rights>Copyright American Thoracic Society Nov 1, 2007</rights><rights>Copyright © 2007, American Thoracic Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c282t-75652930b973f80c8221761e063b49ea9db1223e729be1e1630815f3763b0a073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,4011,4012,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17626910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gajic, Ognjen</creatorcontrib><creatorcontrib>Rana, Rimki</creatorcontrib><creatorcontrib>Winters, Jeffrey L</creatorcontrib><creatorcontrib>Yilmaz, Murat</creatorcontrib><creatorcontrib>Mendez, Jose L</creatorcontrib><creatorcontrib>Rickman, Otis B</creatorcontrib><creatorcontrib>O'Byrne, Megan M</creatorcontrib><creatorcontrib>Evenson, Laura K</creatorcontrib><creatorcontrib>Malinchoc, Michael</creatorcontrib><creatorcontrib>DeGoey, Steven R</creatorcontrib><creatorcontrib>Afessa, Bekele</creatorcontrib><creatorcontrib>Hubmayr, Rolf D</creatorcontrib><creatorcontrib>Moore, S. Breanndan</creatorcontrib><title>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies.
To compare patient and transfusion risk factors between patients who do and do not develop ALI.
In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis.
Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI.
Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.</description><subject>Aged</subject><subject>Alcohol</subject><subject>Antibodies</subject><subject>B. Critical Care</subject><subject>Blood & organ donations</subject><subject>Blood products</subject><subject>Blood Transfusion - methods</subject><subject>Case-Control Studies</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Critical Care</subject><subject>Female</subject><subject>Granulocytes</subject><subject>Humans</subject><subject>Incidence</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Plasma</subject><subject>Respiratory Distress Syndrome - epidemiology</subject><subject>Respiratory Distress Syndrome - therapy</subject><subject>Risk Factors</subject><subject>Sepsis</subject><subject>Time Factors</subject><subject>Transfusion Reaction</subject><subject>Treatment Outcome</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkd2L1DAUxYso7of-Ab5I8EHYh665aZsPH4SlqDsw7Aqu4FtIM7czGdJ2NmlX5r83dYbV9SmB-zuHe-7JsjdALwF4-SFY210ySgVlORNwWz_LTqEqqrxUgj5PfyqKvCzVz5PsLMYtpcAk0JfZCQjOuAJ6mjV3wfSxnaIb-jygNyOuyJWdRiTLqV-TRb-dwp64nowbJHVwo7PG-z1ZeP-RfAtD3KEd3QOSG4yztjYR83roxzB48n2cVvtX2YvW-Iivj-959uPL57v6Ol_efl3UV8vcMsnGXFS8YqqgjRJFK6mVjKU1ASkvmlKhUasGGCtQMNUgIPCCSqjaQqQ5NSnpefbp4Lubmg5XFtMOxutdcJ0Jez0Yp59OerfR6-FBM1pKLqpk8P5oEIb7KcXRnYsWvTc9DlPUXJZQ8nIG3_0Hbocp9CmcBqUqRSsJCYIDZNORYsD2cROgeq5Pz_XpQ336T31J8_bfCH8Vx74ScHEANm69-eUC6tilOhIO2mxnw4RqpaXkxW8eVqUm</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Gajic, Ognjen</creator><creator>Rana, Rimki</creator><creator>Winters, Jeffrey L</creator><creator>Yilmaz, Murat</creator><creator>Mendez, Jose L</creator><creator>Rickman, Otis B</creator><creator>O'Byrne, Megan M</creator><creator>Evenson, Laura K</creator><creator>Malinchoc, Michael</creator><creator>DeGoey, Steven R</creator><creator>Afessa, Bekele</creator><creator>Hubmayr, Rolf D</creator><creator>Moore, S. Breanndan</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071101</creationdate><title>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</title><author>Gajic, Ognjen ; Rana, Rimki ; Winters, Jeffrey L ; Yilmaz, Murat ; Mendez, Jose L ; Rickman, Otis B ; O'Byrne, Megan M ; Evenson, Laura K ; Malinchoc, Michael ; DeGoey, Steven R ; Afessa, Bekele ; Hubmayr, Rolf D ; Moore, S. Breanndan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-75652930b973f80c8221761e063b49ea9db1223e729be1e1630815f3763b0a073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Alcohol</topic><topic>Antibodies</topic><topic>B. Critical Care</topic><topic>Blood & organ donations</topic><topic>Blood products</topic><topic>Blood Transfusion - methods</topic><topic>Case-Control Studies</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Critical Care</topic><topic>Female</topic><topic>Granulocytes</topic><topic>Humans</topic><topic>Incidence</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Plasma</topic><topic>Respiratory Distress Syndrome - epidemiology</topic><topic>Respiratory Distress Syndrome - therapy</topic><topic>Risk Factors</topic><topic>Sepsis</topic><topic>Time Factors</topic><topic>Transfusion Reaction</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gajic, Ognjen</creatorcontrib><creatorcontrib>Rana, Rimki</creatorcontrib><creatorcontrib>Winters, Jeffrey L</creatorcontrib><creatorcontrib>Yilmaz, Murat</creatorcontrib><creatorcontrib>Mendez, Jose L</creatorcontrib><creatorcontrib>Rickman, Otis B</creatorcontrib><creatorcontrib>O'Byrne, Megan M</creatorcontrib><creatorcontrib>Evenson, Laura K</creatorcontrib><creatorcontrib>Malinchoc, Michael</creatorcontrib><creatorcontrib>DeGoey, Steven R</creatorcontrib><creatorcontrib>Afessa, Bekele</creatorcontrib><creatorcontrib>Hubmayr, Rolf D</creatorcontrib><creatorcontrib>Moore, S. Breanndan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gajic, Ognjen</au><au>Rana, Rimki</au><au>Winters, Jeffrey L</au><au>Yilmaz, Murat</au><au>Mendez, Jose L</au><au>Rickman, Otis B</au><au>O'Byrne, Megan M</au><au>Evenson, Laura K</au><au>Malinchoc, Michael</au><au>DeGoey, Steven R</au><au>Afessa, Bekele</au><au>Hubmayr, Rolf D</au><au>Moore, S. Breanndan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>176</volume><issue>9</issue><spage>886</spage><epage>891</epage><pages>886-891</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies.
To compare patient and transfusion risk factors between patients who do and do not develop ALI.
In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis.
Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI.
Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>17626910</pmid><doi>10.1164/rccm.200702-271OC</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 2007-11, Vol.176 (9), p.886-891 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2048675 |
source | MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; Journals@Ovid Complete |
subjects | Aged Alcohol Antibodies B. Critical Care Blood & organ donations Blood products Blood Transfusion - methods Case-Control Studies Cohort analysis Cohort Studies Critical Care Female Granulocytes Humans Incidence Leukocytes Male Middle Aged Mortality Patients Plasma Respiratory Distress Syndrome - epidemiology Respiratory Distress Syndrome - therapy Risk Factors Sepsis Time Factors Transfusion Reaction Treatment Outcome |
title | Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A33%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfusion-related%20Acute%20Lung%20Injury%20in%20the%20Critically%20Ill:%20Prospective%20Nested%20Case-Control%20Study&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Gajic,%20Ognjen&rft.date=2007-11-01&rft.volume=176&rft.issue=9&rft.spage=886&rft.epage=891&rft.pages=886-891&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200702-271OC&rft_dat=%3Cproquest_pubme%3E68414645%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199590581&rft_id=info:pmid/17626910&rfr_iscdi=true |